{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T03:00:43Z","timestamp":1770174043926,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32322048"],"award-info":[{"award-number":["32322048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["22QA1411100"],"award-info":[{"award-number":["22QA1411100"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017291","name":"Zhongshan Science and Technology Bureau","doi-asserted-by":"publisher","award":["CXTD2024006"],"award-info":[{"award-number":["CXTD2024006"]}],"id":[{"id":"10.13039\/501100017291","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Elite Scientists Sponsorship Program by CAST","award":["2022QNRC001"],"award-info":[{"award-number":["2022QNRC001"]}]},{"DOI":"10.13039\/501100012492","name":"Youth Innovation Promotion Association","doi-asserted-by":"crossref","award":["CAS2021276"],"award-info":[{"award-number":["CAS2021276"]}],"id":[{"id":"10.13039\/501100012492","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sanofi scholarship program, Guangdong High-level New R&D Institute, China","award":["Grant No.:2019B090904008"],"award-info":[{"award-number":["Grant No.:2019B090904008"]}]},{"name":"Guangdong High-level Innovative Research Institute, China","award":["Grant No.:2021B0909050003"],"award-info":[{"award-number":["Grant No.:2021B0909050003"]}]},{"DOI":"10.13039\/100020732","name":"Innovative research team of high-level local universities in Shanghai","doi-asserted-by":"crossref","award":["SHSMU-ZDCX20212700"],"award-info":[{"award-number":["SHSMU-ZDCX20212700"]}],"id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["No. 2021YFA0804700"],"award-info":[{"award-number":["No. 2021YFA0804700"]}]},{"name":"Strategic Priority Research Program of the Chinese Academy of Sciences","award":["Grant No. XDB1360000"],"award-info":[{"award-number":["Grant No. XDB1360000"]}]},{"name":"Zhejiang Province Medical and health science and Technology project","award":["2024KY141"],"award-info":[{"award-number":["2024KY141"]}]},{"DOI":"10.13039\/501100018553","name":"Wenzhou Science and Technology Project","doi-asserted-by":"crossref","award":["Y20220186"],"award-info":[{"award-number":["Y20220186"]}],"id":[{"id":"10.13039\/501100018553","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Discipline Cluster of Oncology, Wenzhou Medical University, China","award":["No. z1-2023003"],"award-info":[{"award-number":["No. z1-2023003"]}]},{"name":"Clinical and basic research project of Beijing Kangmeng Charity Foundation Medical Research and Development Fund","award":["CB23005"],"award-info":[{"award-number":["CB23005"]}]},{"name":"National Health Commission Pharmaceutical Health Science and Technology Development Research Center of innovative drug post-marketing clinical research project","award":["WKZX2024CX104301"],"award-info":[{"award-number":["WKZX2024CX104301"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The management of dysbiotic gut microbiota in\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      infection has attracted increasing scholarly attention. The development of therapeutic agents with low toxicity, derived from both the flavonoid xanthohumol and the short-chain fatty acid-producing probiotic\n                      <jats:italic>Clostridium butyricum<\/jats:italic>\n                      , holds considerable promise for combating\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      infection. Despite their therapeutic potential, the molecular mechanisms underlying the anti-\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      effects remain inadequately characterized.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this study, we established a dextran sulfate sodium-induced inflammatory model using Caco-2 intestinal epithelial cells. The protective effects of xanthohumol against\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      infection superimposed on colitis were evaluated through cell viability assays, analysis of inflammatory signaling pathways, and proteomic profiling. Subsequent in vitro assays and proteomic analyses were conducted to assess the influence of xanthohumol and\n                      <jats:italic>Clostridium butyricum<\/jats:italic>\n                      supernatant on\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      . Furthermore, tandem mass tag-based post-translational modification proteomics was employed to elucidate the underlying molecular mechanisms and key pathways. Finally, critical metabolic enzyme activity assays were performed to validate the regulatory roles of these pathways.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Xanthohumol significantly alleviated\n                      <jats:italic>C. difficile<\/jats:italic>\n                      -induced damage in Caco-2 cells, enhanced cell viability, and suppressed the activation of inflammatory signaling pathways. In vitro experiments demonstrated that both xanthohumol and\n                      <jats:italic>C. butyricum<\/jats:italic>\n                      supernatant reduced bacterial colonization, inhibited growth, and attenuated toxin production. Proteomic analyses revealed substantial alterations in the proteome of\n                      <jats:italic>C. difficile<\/jats:italic>\n                      in response to each treatment. Post-translational modification proteomics further indicated that both treatments modulate lysine acetylation levels, influencing glycolysis pathways and ultimately diminishing the pathogen\u2019s virulence. Furthermore, mass spectrometry identified a specific lysine acetylation at the K280 site of fructose-1,6-bisphosphate aldolase, a key enzyme in glycolysis. Functional validation via site-directed mutagenesis confirmed the essential role of this acetylation in regulating the catalytic activity of fructose-1,6-bisphosphate aldolase.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our study demonstrates that xanthohumol and\n                      <jats:italic>Clostridium butyricum<\/jats:italic>\n                      attenuate the pathogenicity of\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      through modulation of lysine acetylation and disruption of glycolysis metabolism. These findings highlight their potential as promising therapeutic strategies for treating\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract:<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01343-x","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T14:53:04Z","timestamp":1770130384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proteomic antibacterial characterization of flavonoid xanthohumol and probiotic Clostridium butyricum on pathogenic Clostridioides difficile"],"prefix":"10.1186","volume":"21","author":[{"given":"Shenkun","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"1343_CR1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-062307","author":"D Shirley","year":"2023","unstructured":"Shirley D, Tornel W, Warren CA, Moonah S. Clostridioides difficile infection in children: recent updates on epidemiology, diagnosis, therapy. Pediatrics. 2023. https:\/\/doi.org\/10.1542\/peds.2023-062307.","journal-title":"Pediatrics"},{"key":"1343_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4102\/sajid.v35i1.219","volume":"1","author":"T Nana","year":"2020","unstructured":"Nana T, Moore C, Boyles T, Brink AJ, Cleghorn J, Devenish LM, et al. South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline. South Afr J Infect Dis. 2020;1:219. https:\/\/doi.org\/10.4102\/sajid.v35i1.219.","journal-title":"South Afr J Infect Dis"},{"key":"1343_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12071141","author":"C Liu","year":"2023","unstructured":"Liu C, Monaghan T, Yadegar A, Louie T, Kao D. Insights into the evolving epidemiology of Clostridioides difficile infection and treatment: a global perspective. Antibiotics-Basel. 2023. https:\/\/doi.org\/10.3390\/antibiotics12071141.","journal-title":"Antibiotics-Basel"},{"key":"1343_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11070819","author":"A Boeriu","year":"2022","unstructured":"Boeriu A, Roman A, Fofiu C, Dobru D. The current knowledge on Clostridioides difficile infection in patients with inflammatory bowel diseases. Pathogens. 2022. https:\/\/doi.org\/10.3390\/pathogens11070819.","journal-title":"Pathogens"},{"key":"1343_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071315","author":"LE Del Vecchio","year":"2022","unstructured":"Del Vecchio LE, Fiorani M, Tohumcu E, Bibbo S, Porcari S, Mele MC, et al. Risk factors, diagnosis, and management of clostridioides difficile infection in patients with inflammatory bowel disease. Microorganisms. 2022. https:\/\/doi.org\/10.3390\/microorganisms10071315.","journal-title":"Microorganisms"},{"key":"1343_CR6","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02733-20","volume":"3","author":"L Abernathy-Close","year":"2021","unstructured":"Abernathy-Close L, Barron MR, George JM, Dieterle MG, Vendrov KC, Bergin IL, et al. Intestinal inflammation and altered gut microbiota associated with inflammatory bowel disease render mice susceptible to clostridioides difficile colonization and infection. MBio. 2021;3:e273320. https:\/\/doi.org\/10.1128\/mBio.02733-20.","journal-title":"MBio"},{"key":"1343_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/jam.12344","volume":"1","author":"X Wu","year":"2014","unstructured":"Wu X, Alam MZ, Feng L, Tsutsumi LS, Sun D, Hurdle JG. Prospects for flavonoid and related phytochemicals as nature-inspired treatments for Clostridium difficile infection. J Appl Microbiol. 2014;1:23\u201331. https:\/\/doi.org\/10.1111\/jam.12344.","journal-title":"J Appl Microbiol"},{"key":"1343_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27041281","author":"W Liu","year":"2022","unstructured":"Liu W, He K, Wu D, Zhou L, Li G, Lin Z, et al. Natural dietary compound xanthohumol regulates the gut microbiota and its metabolic profile in a mouse model of alzheimer\u2019s disease. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27041281.","journal-title":"Molecules"},{"key":"1343_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12747","author":"P Cermak","year":"2017","unstructured":"Cermak P, Olsovska J, Mikyska A, Dusek M, Kadleckova Z, Vanicek J, et al. Strong antimicrobial activity of xanthohumol and other derivatives from hops (Humulus lupulus L.) on gut anaerobic bacteria. APMIS. 2017. https:\/\/doi.org\/10.1111\/apm.12747.","journal-title":"APMIS"},{"key":"1343_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/tox.22849","volume":"2","author":"H Liu","year":"2020","unstructured":"Liu H, Zhang L, Li G, Gao Z. Xanthohumol protects against Azoxymethane-induced colorectal cancer in Sprague-Dawley rats. Environ Toxicol. 2020;2:136\u201344. https:\/\/doi.org\/10.1002\/tox.22849.","journal-title":"Environ Toxicol"},{"key":"1343_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153233","author":"MT Khayyal","year":"2020","unstructured":"Khayyal MT, El-Hazek RM, El-Sabbagh WA, Frank J, Behnam D, Abdel-Tawab M. Micellar solubilization enhances the anti-inflammatory effect of xanthohumol. Phytomedicine. 2020. https:\/\/doi.org\/10.1016\/j.phymed.2020.153233.","journal-title":"Phytomedicine"},{"key":"1343_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2315633","author":"PE Jamieson","year":"2024","unstructured":"Jamieson PE, Smart EB, Bouranis JA, Choi J, Danczak RE, Wong CP, et al. Gut enterotype-dependent modulation of gut microbiota and their metabolism in response to xanthohumol supplementation in healthy adults. Gut Microbes. 2024. https:\/\/doi.org\/10.1080\/19490976.2024.2315633.","journal-title":"Gut Microbes"},{"key":"1343_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10040392","author":"R Sleha","year":"2021","unstructured":"Sleha R, Radochova V, Mikyska A, Houska M, Bolehovska R, Janovska S, et al. Strong antimicrobial effects of xanthohumol and beta-acids from hops against Clostridioides difficile infection in vivo. Antibiotics-Basel. 2021. https:\/\/doi.org\/10.3390\/antibiotics10040392.","journal-title":"Antibiotics-Basel"},{"key":"1343_CR14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-030320-095722","author":"RM Jones","year":"2021","unstructured":"Jones RM, Neish AS. Gut microbiota in intestinal and liver disease. Annu Rev Pathol-Mech Dis. 2021. https:\/\/doi.org\/10.1146\/annurev-pathol-030320-095722.","journal-title":"Annu Rev Pathol-Mech Dis"},{"key":"1343_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2018.12.003","author":"F Chen","year":"2019","unstructured":"Chen F, Stappenbeck TS. Microbiome control of innate reactivity. Curr Opin Immunol. 2019. https:\/\/doi.org\/10.1016\/j.coi.2018.12.003.","journal-title":"Curr Opin Immunol"},{"key":"1343_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.42","author":"MG Rooks","year":"2016","unstructured":"Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016. https:\/\/doi.org\/10.1038\/nri.2016.42.","journal-title":"Nat Rev Immunol"},{"key":"1343_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-018-0549-0","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhao Y. Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell. 2018. https:\/\/doi.org\/10.1007\/s13238-018-0549-0.","journal-title":"Protein Cell"},{"key":"1343_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/113.8.1613","author":"SE Fleming","year":"1983","unstructured":"Fleming SE, Rodriguez MA. Influence of dietary fiber on fecal excretion of volatile fatty acids by human adults. J Nutr. 1983. https:\/\/doi.org\/10.1093\/jn\/113.8.1613.","journal-title":"J Nutr"},{"key":"1343_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2012.156","author":"HJ Flint","year":"2012","unstructured":"Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012. https:\/\/doi.org\/10.1038\/nrgastro.2012.156.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1343_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.12.003","author":"L Zhang","year":"2021","unstructured":"Zhang L, Liu C, Jiang Q, Yin Y. Butyrate in energy metabolism: there is still more to learn. Trends Endocrinol Metab. 2021. https:\/\/doi.org\/10.1016\/j.tem.2020.12.003.","journal-title":"Trends Endocrinol Metab"},{"key":"1343_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020483","author":"T Ariyoshi","year":"2022","unstructured":"Ariyoshi T, Hagihara M, Takahashi M, Mikamo H. Effect of Clostridium butyricum on gastrointestinal infections. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10020483.","journal-title":"Biomedicines"},{"key":"1343_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01264","author":"K Oka","year":"2018","unstructured":"Oka K, Osaki T, Hanawa T, Kurata S, Sugiyama E, Takahashi M, et al. Establishment of an endogenous Clostridium difficile rat infection model and evaluation of the effects of Clostridium butyricum MIYAIRI 588 probiotic strain. Front Microbiol. 2018. https:\/\/doi.org\/10.3389\/fmicb.2018.01264.","journal-title":"Front Microbiol"},{"key":"1343_CR23","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.033423-0","author":"TDH Woo","year":"2011","unstructured":"Woo TDH, Oka K, Takahashi M, Hojo F, Osaki T, Hanawa T, et al. Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain. J Med Microbiol. 2011. https:\/\/doi.org\/10.1099\/jmm.0.033423-0.","journal-title":"J Med Microbiol"},{"key":"1343_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0407992101","author":"J Chen","year":"2004","unstructured":"Chen J, Chang Y, Yao C, Chiueh T, Huang S, Chien K, et al. Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proc Natl Acad Sci U S A. 2004. https:\/\/doi.org\/10.1073\/pnas.0407992101.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1343_CR25","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1074\/mcp.M112.018846","volume":"5","author":"J Albrethsen","year":"2013","unstructured":"Albrethsen J, Agner J, Piersma SR, Hojrup P, Pham TV, Weldingh K, et al. Proteomic profiling of Mycobacterium tuberculosis identifies nutrient-starvation-responsive toxin-antitoxin systems. Mol Cell Proteomics. 2013;5:1180\u201391. https:\/\/doi.org\/10.1074\/mcp.M112.018846.","journal-title":"Mol Cell Proteomics"},{"key":"1343_CR26","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/prca.201600035","volume":"9","author":"E Richter","year":"2016","unstructured":"Richter E, Mostertz J, Hochgrafe F. Proteomic discovery of host kinase signaling in bacterial infections. Proteomics Clin Appl. 2016;9:994\u20131010. https:\/\/doi.org\/10.1002\/prca.201600035.","journal-title":"Proteomics Clin Appl"},{"key":"1343_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2554","author":"JE Huddleston","year":"2011","unstructured":"Huddleston JE. Bacterial pathogenesis. Neisseria meningitidis: hit and run. Nat Rev Microbiol. 2011. https:\/\/doi.org\/10.1038\/nrmicro2554.","journal-title":"Nat Rev Microbiol"},{"key":"1343_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/treephys\/tpae051","volume":"6","author":"X Liu","year":"2024","unstructured":"Liu X, Ye J, Zhang X, Yang K, Zheng J, Cheng S, et al. Multi-omics explores the potential regulatory role of acetylation modification in flavonoid biosynthesis of Ginkgo biloba. Tree Physiol. 2024;6:e51. https:\/\/doi.org\/10.1093\/treephys\/tpae051.","journal-title":"Tree Physiol"},{"key":"1343_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-025-01183-w","author":"I Mukhopadhya","year":"2025","unstructured":"Mukhopadhya I, Louis P. Gut microbiota-derived short-chain fatty acids and their role in human health and disease. Nat Rev Microbiol. 2025. https:\/\/doi.org\/10.1038\/s41579-025-01183-w.","journal-title":"Nat Rev Microbiol"},{"key":"1343_CR30","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.001306","author":"JKJ Cheng","year":"2023","unstructured":"Cheng JKJ, Unnikrishnan M. Clostridioides difficile infection: Traversing host-pathogen interactions in the gut. Microbiol-Sgm. 2023. https:\/\/doi.org\/10.1099\/mic.0.001306.","journal-title":"Microbiol-Sgm"},{"key":"1343_CR31","doi-asserted-by":"publisher","DOI":"10.3791\/50787","volume":"79","author":"AN Edwards","year":"2013","unstructured":"Edwards AN, Suarez JM, Mcbride SM. Culturing and maintaining Clostridium difficile in an anaerobic environment. Jove-J Vis Exp. 2013;79:e50787. https:\/\/doi.org\/10.3791\/50787.","journal-title":"Jove-J Vis Exp"},{"key":"1343_CR32","doi-asserted-by":"publisher","DOI":"10.1615\/IntJMedMushrooms.2025058082","author":"J Lin","year":"2025","unstructured":"Lin J, Yuan M, Shi H, Liu Q, Du S, Zhang M, et al. Phellinus linteus (Agaricomycetes) polysaccharides ameliorate inflammatory injury in H2O2-induced caco-2 cells and DSS-induced ulcerative colitis mice. Int J Med Mushrooms. 2025. https:\/\/doi.org\/10.1615\/IntJMedMushrooms.2025058082.","journal-title":"Int J Med Mushrooms"},{"key":"1343_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2024.104626","author":"X Gao","year":"2024","unstructured":"Gao X, Xia Y, Sun X, Dou W, Chen R, Huang P, et al. Bifidobacterium breve modulates lactic acid to curtail Escherichia coli expansion and alleviate inflammatory bowel disease. Food Biosci. 2024. https:\/\/doi.org\/10.1016\/j.fbio.2024.104626.","journal-title":"Food Biosci"},{"key":"1343_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00424-19","author":"J Xu","year":"2020","unstructured":"Xu J, Zhao L, Xu Y, Li B, Zhai L, Tan M, et al. Dynamic characterization of protein and posttranslational modification levels in mycobacterial cholesterol catabolism. mSystems. 2020. https:\/\/doi.org\/10.1128\/mSystems.00424-19.","journal-title":"mSystems"},{"key":"1343_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1006\/abbi.1998.0725","volume":"2","author":"RJ Hodgson","year":"1998","unstructured":"Hodgson RJ, Plaxton WC. Purification and characterization of cytosolic fructose-1, 6-bisphosphate aldolase from endosperm of germinated castor oil seeds. Arch Biochem Biophys. 1998;2:189\u201396. https:\/\/doi.org\/10.1006\/abbi.1998.0725.","journal-title":"Arch Biochem Biophys"},{"key":"1343_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.136","volume":"4","author":"Y Liu","year":"2023","unstructured":"Liu Y, Duan H, Chen Y, Zhang C, Zhao J, Narbad A, et al. Intraspecific difference of Latilactobacillus sakei in inflammatory bowel diseases: insights into potential mechanisms through comparative genomics and metabolomics analyses. IMeta. 2023;4:e136. https:\/\/doi.org\/10.1002\/imt2.136.","journal-title":"IMeta"},{"key":"1343_CR37","doi-asserted-by":"publisher","first-page":"11897","DOI":"10.3390\/ijms262411897","volume":"24","author":"P Rzeczycki","year":"2025","unstructured":"Rzeczycki P, P\u0119ciak O, Plust M, Dro\u017adzik M. Gut microbiota in the regulation of intestinal drug transporters: molecular mechanisms and pharmacokinetic implications. Int J Mol Sci. 2025;24:11897. https:\/\/doi.org\/10.3390\/ijms262411897.","journal-title":"Int J Mol Sci"},{"key":"1343_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1277102","author":"Y Fu","year":"2023","unstructured":"Fu Y, Lyu J, Wang S. The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1277102.","journal-title":"Front Immunol"},{"key":"1343_CR39","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000914","author":"Z Che","year":"2025","unstructured":"Che Z, Xue W, Zhao X, Hu C, Tian Y. Regulatory role and biomarker potential of gut microbiota metabolites in the progression of metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma. Clin Transl Gastroenterol. 2025. https:\/\/doi.org\/10.14309\/ctg.0000000000000914.","journal-title":"Clin Transl Gastroenterol"},{"key":"1343_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00586-19","author":"AN Edwards","year":"2020","unstructured":"Edwards AN, Krall EG, Mcbride SM. Strain-dependent RstA regulation of Clostridioides difficile toxin production and sporulation. J Bacteriol. 2020. https:\/\/doi.org\/10.1128\/JB.00586-19.","journal-title":"J Bacteriol"},{"key":"1343_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq973","author":"D Szklarczyk","year":"2011","unstructured":"Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011. https:\/\/doi.org\/10.1093\/nar\/gkq973.","journal-title":"Nucleic Acids Res"},{"key":"1343_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.719678","author":"DB Pirovich","year":"2021","unstructured":"Pirovich DB, Da\u2019Dara AA, Skelly PJ. Multifunctional fructose 1,6-bisphosphate aldolase as a therapeutic target. Front Mol Biosci. 2021. https:\/\/doi.org\/10.3389\/fmolb.2021.719678.","journal-title":"Front Mol Biosci"},{"key":"1343_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2007.10.008","author":"P Natarajan","year":"2008","unstructured":"Natarajan P, Katta S, Andrei I, Babu Rao Ambati V, Leonida M, Haas GJ. Positive antibacterial co-action between hop (Humulus lupulus) constituents and selected antibiotics. Phytomedicine. 2008. https:\/\/doi.org\/10.1016\/j.phymed.2007.10.008.","journal-title":"Phytomedicine"},{"key":"1343_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01852","author":"S Di Lodovico","year":"2020","unstructured":"Di Lodovico S, Menghini L, Ferrante C, Recchia E, Castro-Amorim J, Gameiro P, et al. Hop extract: an efficacious antimicrobial and anti-biofilm agent against multidrug-resistant staphylococci strains and cutibacterium acnes. Front Microbiol. 2020. https:\/\/doi.org\/10.3389\/fmicb.2020.01852.","journal-title":"Front Microbiol"},{"key":"1343_CR45","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112333","volume":"13","author":"Y Sun","year":"2023","unstructured":"Sun Y, Zhang Y, Zhao T, Luan Y, Wang Y, Yang C, et al. Acetylation coordinates the crosstalk between carbon metabolism and ammonium assimilation in Salmonella enterica. EMBO J. 2023;13:e112333. https:\/\/doi.org\/10.15252\/embj.2022112333.","journal-title":"EMBO J"},{"key":"1343_CR46","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1074\/mcp.RA117.000372","volume":"6","author":"J Xu","year":"2018","unstructured":"Xu J, Xu Z, Liu X, Tan M, Ye B. Protein acetylation and butyrylation regulate the phenotype and metabolic shifts of the endospore-forming clostridium acetobutylicum. Mol Cell Proteomics. 2018;6:1156\u201369. https:\/\/doi.org\/10.1074\/mcp.RA117.000372.","journal-title":"Mol Cell Proteomics"},{"key":"1343_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s42995-025-00305-w","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, He Y, Xie Z, Bai Z, Hu G, Wang M, et al. Phosphoproteomics reveals essential regulatory roles of phosphorylation in marine oligotrophic bacteria. Mar Life Sci Technol. 2025. https:\/\/doi.org\/10.1007\/s42995-025-00305-w.","journal-title":"Mar Life Sci Technol"},{"key":"1343_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8050153","author":"I Martin-Verstraete","year":"2016","unstructured":"Martin-Verstraete I, Peltier J, Dupuy B. The regulatory networks that control Clostridium difficile toxin synthesis. Toxins. 2016. https:\/\/doi.org\/10.3390\/toxins8050153.","journal-title":"Toxins"},{"key":"1343_CR49","doi-asserted-by":"publisher","DOI":"10.1128\/aem.61.6.2425-2427.1995","author":"MT Kazamias","year":"1995","unstructured":"Kazamias MT, Sperry JF. Enhanced fermentation of mannitol and release of cytotoxin by Clostridium difficile in alkaline culture media. Appl Environ Microbiol. 1995. https:\/\/doi.org\/10.1128\/aem.61.6.2425-2427.1995.","journal-title":"Appl Environ Microbiol"},{"key":"1343_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2958.1998.00663.x","volume":"1","author":"B Dupuy","year":"1998","unstructured":"Dupuy B, Sonenshein AL. Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol. 1998;1:107\u201320. https:\/\/doi.org\/10.1046\/j.1365-2958.1998.00663.x.","journal-title":"Mol Microbiol"},{"key":"1343_CR51","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1128\/JB.184.21.5971-5978.2002","volume":"21","author":"N Mani","year":"2002","unstructured":"Mani N, Lyras D, Barroso L, Howarth P, Wilkins T, Rood JI, et al. Environmental response and autoregulation of Clostridium difficile TxeR, a sigma factor for toxin gene expression. J Bacteriol. 2002;21:5971\u20138. https:\/\/doi.org\/10.1128\/JB.184.21.5971-5978.2002.","journal-title":"J Bacteriol"},{"key":"1343_CR52","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00138-23","volume":"9","author":"MA Baldassare","year":"2023","unstructured":"Baldassare MA, Bhattacharjee D, Coles JD, Nelson S, Mccollum CA, Seekatz AM. Butyrate enhances Clostridioides difficile sporulation in vitro. J Bacteriol. 2023;9:e13823. https:\/\/doi.org\/10.1128\/jb.00138-23.","journal-title":"J Bacteriol"},{"key":"1343_CR53","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.cell.2025.01.045","volume":"7","author":"GA Kuziel","year":"2025","unstructured":"Kuziel GA, Lozano GL, Simian C, Li L, Manion J, Stephen-Victor E, et al. Functional diversification of dietary plant small molecules by the gut microbiome. Cell. 2025;7:1967\u201383. https:\/\/doi.org\/10.1016\/j.cell.2025.01.045.","journal-title":"Cell"},{"key":"1343_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304833","author":"K Machiels","year":"2014","unstructured":"Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014. https:\/\/doi.org\/10.1136\/gutjnl-2013-304833.","journal-title":"Gut"},{"key":"1343_CR55","doi-asserted-by":"publisher","DOI":"10.1159\/000441768","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Nishida A, Fujimoto T, Fujii M, Shioya M, Imaeda H, et al. Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn\u2019s disease. Digestion. 2016. https:\/\/doi.org\/10.1159\/000441768.","journal-title":"Digestion"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01343-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01343-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01343-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T14:53:07Z","timestamp":1770130387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01343-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01343-x","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}